par Driessens, Grégory
;Harsan, Laura;Browaeys, Patrick
;Giannakopoulos, Xenofon;Velu, Thierry
;Bruyns, Catherine 
Référence Annals of the New York Academy of Sciences, 1010, page (775-779)
Publication Publié, 2003-12




Référence Annals of the New York Academy of Sciences, 1010, page (775-779)
Publication Publié, 2003-12
Article révisé par les pairs
Titre: |
|
Auteur: | Driessens, Grégory; Harsan, Laura; Browaeys, Patrick; Giannakopoulos, Xenofon; Velu, Thierry; Bruyns, Catherine |
Informations sur la publication: | Annals of the New York Academy of Sciences, 1010, page (775-779) |
Statut de publication: | Publié, 2003-12 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Animals |
Antineoplastic Agents -- therapeutic use | |
Apoptosis -- drug effects -- radiation effects | |
Brain Neoplasms -- drug therapy -- genetics -- pathology -- radiotherapy | |
Cisplatin -- therapeutic use | |
DNA Damage -- drug effects | |
Genes, p53 | |
Gliosarcoma -- drug therapy -- genetics -- pathology -- radiotherapy | |
In Situ Nick-End Labeling | |
Micronucleus Tests | |
Mutation | |
Rats | |
Note publication spéciale: | Apoptosis from Signaling Pathways to Therapeutic Tools |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
FLWIN | |
Langue: | Anglais |
Identificateurs: | urn:issn:0077-8923 |
info:doi/10.1196/annals.1299.139 | |
info:pmid/15033826 |